RELVAR ELLIPTA pdr inh 184mcg/22mcg 30 dos
7680629690023
CH-62969
R03AK10
03.04.3.
Active substances:
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6296902
- CPT
- -
- Packaging group
- 30
- Unit
- Einzeldose(n)
- Composition
- fluticasoni furoas 184 µg, vilanterolum 22 µg ut vilanteroli trifenatas, magnesii stearas, lactosum monohydricum, ad pulverem pro dosi, doses pro vase 30.
Articles (1)
Relvar Ellipta 184/22 mcg, Einzeldosiertes Pulver zur Inhalation
Einzeldosiertes Pulver zur Inhalation
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fluticasoni furoas
|
184.0 UG | Substance | Wirkstoff (Principe actif) |
|
vilanterolum
|
22.0 UG | Substance | Wirkstoff (Principe actif) |
|
vilanteroli trifenatas
|
- | Substance | WIZUS |
|
magnesii stearas
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 52.30
Specialties list
Yes
Generic
No
SL addition date:
01/02/2014
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 62969
- Drug name
- Relvar Ellipta, Einzeldosiertes Pulver zur Inhalation
- Galenic form
- PULIN
- ATC Code
- R03AK10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 09/01/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RELVAR ELLIPTA pdr inh 184mcg/22mcg 30 dos
- Description (DE)
- RELVAR ELLIPTA Inh Plv 184mcg/22mcg 30 Dos
- Market launch
- 09/01/2014
- Narcotic (BTM)
- No